Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $282,065PUBT·3 hours agoCYTK-0.33%
Cytokinetics to Announce Second Quarter Results on August 6, 2026Unusual Whales·4 hours agoCYTK-0.33%
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CYTK Stock NewsStockTitan·Jul 17 at 07:00 AMCYTK-0.33%
Cytokinetics (CYTK) Could Be 22% Undervalued On Its Growth NarrativeSimplywall·Jul 15 at 08:08 AMCYTK-0.33%
Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $615,150PUBT·Jul 14 at 02:35 PMCYTK-0.33%
How Myqorzo’s US and German Launches Will Impact Cytokinetics (CYTK) InvestorsSimplywall·Jul 12 at 12:02 AMCYTK-0.33%
Cytokinetics, Incorporated Stock 12‑Month Price Target Raised to $108.47, Implies 26% UpsideTradingView·Jul 10 at 02:20 AMCYTK-0.33%
Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares worth $303,170PUBT·Jul 7 at 04:07 PMCYTK-0.33%
Small-cap surge: Russell 2000 on track for best year since 1991MSN·Jul 7 at 08:57 AMBSPM0.00%CYTK-0.33%
Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026Unusual Whales·Jul 7 at 06:31 AMCYTK-0.33%
Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of Eli Lilly and Company (NYSE:LLY)Market Beat·Jul 4 at 04:02 AMRY-1.41%HQY-1.69%
